Status:
TERMINATED
Developing Affective HeaLth to Improve Adherence to Health Behaviors in Diabetes (DAHLIA II)
Lead Sponsor:
Happify Inc.
Collaborating Sponsors:
Northwestern University
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Participants will be randomly assigned to either a positive affect skills intervention or a psychoeducation control group and assessed with questionnaires before, during, and after the 8-week program,...
Detailed Description
Participants will be randomly assigned to either the Diabetes positive affect skills intervention or a psychoeducation control group. Both programs last 8 weeks and take place on a simplified research...
Eligibility Criteria
Inclusion
- Adults with Type 2 Diabetes
- Elevated HbA1c levels (7 or greater)
- No prior experience on the Happify platform (new user registration)
- PHQ-8 score of 13 or higher
- US resident
- Under the care of a medical professional for the treatment of their diabetes
- Be willing and able to obtain HbA1c every 3 months
Exclusion
- none
Key Trial Info
Start Date :
August 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04068805
Start Date
August 31 2020
End Date
July 12 2022
Last Update
July 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Happify (an online platform -- study is entirely online)
New York, New York, United States, 10012